[HTML][HTML] Risk–benefit profile of direct-acting oral anticoagulants in established therapeutic indications: an overview of systematic reviews and observational studies
E Raschi, M Bianchin, W Ageno, R De Ponti, F De Ponti - Drug safety, 2016 - Springer
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies.
E Raschi, M Bianchin, W Ageno, R De Ponti… - Drug …, 2016 - search.ebscohost.com
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
E Raschi, M Bianchin, W Ageno, R De Ponti… - Drug …, 2016 - pubmed.ncbi.nlm.nih.gov
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
E Raschi, M Bianchin, W Ageno, R De Ponti… - Drug …, 2016 - search.proquest.com
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
[HTML][HTML] Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational …
E Raschi, M Bianchin, W Ageno, R De Ponti… - Drug Safety, 2016 - ncbi.nlm.nih.gov
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
E Raschi, M Bianchin, W Ageno, R De Ponti… - Drug …, 2016 - econpapers.repec.org
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
[PDF][PDF] Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
E Raschi, M Bianchin, W Ageno, R De Ponti, F De Ponti - cyberleninka.org
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
E Raschi, M Bianchin, W Ageno, R DE PONTI… - DRUG …, 2016 - irinsubria.uninsubria.it
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
[PDF][PDF] Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
E Raschi, M Bianchin, W Ageno, R De Ponti, F De Ponti - researchgate.net
Since 2008, the direct-acting oral anticoagulants (DOACs) have expanded the therapeutic
options of cardiovascular diseases with recognized clinical and epidemiological impact …
options of cardiovascular diseases with recognized clinical and epidemiological impact …
[引用][C] Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
E Raschi, M Bianchin, W Ageno, R De Ponti, F De Ponti - Drug Safety, 2016 - cir.nii.ac.jp
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications:
An Overview of Systematic Reviews and Observational Studies | CiNii Research CiNii 国立 …
An Overview of Systematic Reviews and Observational Studies | CiNii Research CiNii 国立 …